Article Abstract
Letter to the Editor
Sir: We appreciate the comments made by Dr. Swartz on our
recent report of electroconvulsive therapy (ECT) in the treatment
of atypical depression. We agree that our study was limited
due to the lack of a placebo control group and to the use of
the 24-item Hamilton Rating Scale for Depression (HAM-D-
24). Without a placebo control, we cannot be certain that ECT
was beneficial in treating severely depressed patients with
atypical features in the acute phase (i.e., spontaneous improvement
could have occurred).
About the Authors
-
Mustafa M. HusainView full profile
-
Rebecca G. KnappView full profile
-
Martina MuellerView full profile
-
Teresa A. RummansView full profile
-
Georgios PetridesView full profile
-
Max FinkView full profile
-
Charles H. KellnerView full profile
-
A. John RushView full profile
-
Melanie M. BiggsView full profile
-
Shawn M. McClintockView full profile
-
Sarah H. LisanbyView full profile
-
Samuel H. BailineView full profile
-
Shirlene SampsonView full profile
-
Cynthia ClaassenView full profile
Download Free PDF
This PDF is free for all visitors!
Related JCP Articles
Neural Dysconnectivity and Affective Disorders: Integrating Sleep and Emotional Regulation Perspectives
Triple Network Dysconnectivity and Sleep Disturbance in Young People With Suicidal Ideation: Reply to Ferruzzi et al
Temporal Dynamics of Antidepressant Response Following Brexanolone Treatment in Postpartum Depression
Related PCC Articles